HEADER TRANSFERASE 05-SEP-13 4C4F TITLE STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE TITLE 2 INHIBITORS OF THE MITOTIC KINASE MPS1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 519-808; COMPND 5 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE, PYT, COMPND 6 MONOPOLAR SPINDLE KINASE 1, MPS1; COMPND 7 EC: 2.7.12.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: AI KEYWDS TRANSFERASE, PROTEIN KINASE, MITOSIS, STRUCTURE-BASED DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR S.NAUD,I.M.WESTWOOD,A.FAISAL,P.SHELDRAKE,V.BAVETSIAS,B.ATRASH,M.LIU, AUTHOR 2 A.HAYES,J.SCHMITT,A.WOOD,V.CHOI,K.BOXALL,G.MAK,M.GURDEN,M.VALENTI, AUTHOR 3 A.DE HAVEN BRANDON,A.HENLEY,R.BAKER,C.MCANDREW,B.MATIJSSEN,R.BURKE, AUTHOR 4 S.A.ECCLES,F.I.RAYNAUD,S.LINARDOPOULOS,R.VAN MONTFORT,J.BLAGG REVDAT 4 20-NOV-24 4C4F 1 REMARK REVDAT 3 20-DEC-23 4C4F 1 REMARK LINK REVDAT 2 15-JAN-14 4C4F 1 JRNL REVDAT 1 04-DEC-13 4C4F 0 JRNL AUTH S.NAUD,I.M.WESTWOOD,A.FAISAL,P.W.SHELDRAKE,V.BAVETSIAS, JRNL AUTH 2 B.ATRASH,K.J.CHEUNG,M.LIU,A.HAYES,J.SCHMITT,A.WOOD,V.CHOI, JRNL AUTH 3 K.BOXALL,G.MAK,M.GURDEN,M.VALENTI,A.DE-HAVEN-BRANDON, JRNL AUTH 4 A.HENLEY,R.BAKER,C.MCANDREW,B.MATIJSSEN,R.BURKE,S.HOELDER, JRNL AUTH 5 S.A.ECCLES,F.I.RAYNAUD,S.LINARDOPOULOS,R.L.M.VAN MONTFORT, JRNL AUTH 6 J.BLAGG JRNL TITL STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE 1H-PYRROLO[3, JRNL TITL 2 2-C]PYRIDINE INHIBITORS OF THE MITOTIC KINASE MONOPOLAR JRNL TITL 3 SPINDLE 1 (MPS1). JRNL REF J.MED.CHEM. V. 56 10045 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24256217 JRNL DOI 10.1021/JM401395S REMARK 2 REMARK 2 RESOLUTION. 2.36 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.36 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 18179 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 933 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.36 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.50 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.99 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2803 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2189 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2642 REMARK 3 BIN R VALUE (WORKING SET) : 0.2172 REMARK 3 BIN FREE R VALUE : 0.2468 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.74 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 161 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1999 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 28 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 67.23 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.13480 REMARK 3 B22 (A**2) : 3.72780 REMARK 3 B33 (A**2) : -9.86260 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.344 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.206 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.175 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.209 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.178 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2106 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2847 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 710 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 53 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 318 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2106 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 278 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2434 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.92 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.46 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -4.5723 -23.1533 -16.6859 REMARK 3 T TENSOR REMARK 3 T11: -0.6686 T22: -0.5741 REMARK 3 T33: -0.4846 T12: 0.0154 REMARK 3 T13: -0.0153 T23: -0.1063 REMARK 3 L TENSOR REMARK 3 L11: 5.2204 L22: 2.5953 REMARK 3 L33: 1.6811 L12: 1.4728 REMARK 3 L13: -0.8174 L23: 0.5065 REMARK 3 S TENSOR REMARK 3 S11: 0.1242 S12: -0.5278 S13: 0.1793 REMARK 3 S21: 0.1815 S22: -0.1474 S23: 0.1493 REMARK 3 S31: 0.0451 S32: -0.1041 S33: 0.0232 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4C4F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1290058236. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JUL-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9173 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18181 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.360 REMARK 200 RESOLUTION RANGE LOW (A) : 59.730 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.36 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.87000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4BI1 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30-35% AQUEOUS PEG300 ONLY, PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.29000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.66500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 56.06000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.29000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.66500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.06000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.29000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.66500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.06000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.29000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.66500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.06000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 496 REMARK 465 HIS A 497 REMARK 465 HIS A 498 REMARK 465 HIS A 499 REMARK 465 HIS A 500 REMARK 465 HIS A 501 REMARK 465 HIS A 502 REMARK 465 SER A 503 REMARK 465 SER A 504 REMARK 465 GLY A 505 REMARK 465 VAL A 506 REMARK 465 ASP A 507 REMARK 465 LEU A 508 REMARK 465 GLY A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 ASN A 512 REMARK 465 LEU A 513 REMARK 465 TYR A 514 REMARK 465 MET A 671 REMARK 465 GLN A 672 REMARK 465 PRO A 673 REMARK 465 ASP A 674 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 LYS A 680 REMARK 465 ASP A 681 REMARK 465 SER A 682 REMARK 465 MET A 698 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 SER A 709 REMARK 465 LYS A 710 REMARK 465 THR A 795 REMARK 465 HIS A 796 REMARK 465 PRO A 797 REMARK 465 VAL A 798 REMARK 465 ASN A 799 REMARK 465 GLN A 800 REMARK 465 MET A 801 REMARK 465 ALA A 802 REMARK 465 LYS A 803 REMARK 465 GLY A 804 REMARK 465 THR A 805 REMARK 465 THR A 806 REMARK 465 GLU A 807 REMARK 465 GLU A 808 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 515 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 516 CG CD OE1 NE2 REMARK 470 ARG A 523 CD NE CZ NH1 NH2 REMARK 470 LYS A 538 CD CE NZ REMARK 470 LYS A 546 CG CD CE NZ REMARK 470 LYS A 547 CD CE NZ REMARK 470 GLU A 559 CG CD OE1 OE2 REMARK 470 GLN A 563 CG CD OE1 NE2 REMARK 470 LYS A 577 CD CE NZ REMARK 470 LYS A 614 CD CE NZ REMARK 470 LYS A 615 CG CD CE NZ REMARK 470 LYS A 616 CG CD CE NZ REMARK 470 LYS A 617 CG CD CE NZ REMARK 470 SER A 618 OG REMARK 470 GLN A 670 CG CD OE1 NE2 REMARK 470 VAL A 684 CG1 CG2 REMARK 470 LYS A 696 CE NZ REMARK 470 ASP A 697 CG OD1 OD2 REMARK 470 ILE A 711 CG1 CG2 CD1 REMARK 470 ILE A 738 CG1 CG2 CD1 REMARK 470 GLU A 753 CG CD OE1 OE2 REMARK 470 GLU A 755 CG CD OE1 OE2 REMARK 470 LYS A 762 CE NZ REMARK 470 LYS A 769 CD CE NZ REMARK 470 LYS A 773 CE NZ REMARK 470 LYS A 777 CG CD CE NZ REMARK 470 GLN A 794 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 647 45.01 -145.98 REMARK 500 TPO A 686 134.58 -36.14 REMARK 500 LEU A 772 34.60 -91.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 7PE A 1796 REMARK 610 7PE A 1797 REMARK 610 7PE A 1798 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PE A 1796 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PE A 1797 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7PE A 1798 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7CE A 1799 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C4E RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 900 RELATED ID: 4C4G RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 900 RELATED ID: 4C4H RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 900 RELATED ID: 4C4I RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 900 RELATED ID: 4C4J RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF ORALLY BIOAVAILABLE PYRROLOPYRIDINE REMARK 900 INHIBITORS OF THE MITOTIC KINASE MPS1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE INCLUDING HEXAHISTIDINE TAG IS AS DESCRIBED REMARK 999 IN NAT. CHEM. BIOL. 2010, 6, 259-368. DBREF 4C4F A 519 808 UNP P33981 TTK_HUMAN 519 808 SEQADV 4C4F MET A 496 UNP P33981 EXPRESSION TAG SEQADV 4C4F HIS A 497 UNP P33981 EXPRESSION TAG SEQADV 4C4F HIS A 498 UNP P33981 EXPRESSION TAG SEQADV 4C4F HIS A 499 UNP P33981 EXPRESSION TAG SEQADV 4C4F HIS A 500 UNP P33981 EXPRESSION TAG SEQADV 4C4F HIS A 501 UNP P33981 EXPRESSION TAG SEQADV 4C4F HIS A 502 UNP P33981 EXPRESSION TAG SEQADV 4C4F SER A 503 UNP P33981 EXPRESSION TAG SEQADV 4C4F SER A 504 UNP P33981 EXPRESSION TAG SEQADV 4C4F GLY A 505 UNP P33981 EXPRESSION TAG SEQADV 4C4F VAL A 506 UNP P33981 EXPRESSION TAG SEQADV 4C4F ASP A 507 UNP P33981 EXPRESSION TAG SEQADV 4C4F LEU A 508 UNP P33981 EXPRESSION TAG SEQADV 4C4F GLY A 509 UNP P33981 EXPRESSION TAG SEQADV 4C4F THR A 510 UNP P33981 EXPRESSION TAG SEQADV 4C4F GLU A 511 UNP P33981 EXPRESSION TAG SEQADV 4C4F ASN A 512 UNP P33981 EXPRESSION TAG SEQADV 4C4F LEU A 513 UNP P33981 EXPRESSION TAG SEQADV 4C4F TYR A 514 UNP P33981 EXPRESSION TAG SEQADV 4C4F PHE A 515 UNP P33981 EXPRESSION TAG SEQADV 4C4F GLN A 516 UNP P33981 EXPRESSION TAG SEQADV 4C4F SER A 517 UNP P33981 EXPRESSION TAG SEQADV 4C4F MET A 518 UNP P33981 EXPRESSION TAG SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 313 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER VAL LYS SEQRES 3 A 313 GLY ARG ILE TYR SER ILE LEU LYS GLN ILE GLY SER GLY SEQRES 4 A 313 GLY SER SER LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS SEQRES 5 A 313 GLN ILE TYR ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA SEQRES 6 A 313 ASP ASN GLN THR LEU ASP SER TYR ARG ASN GLU ILE ALA SEQRES 7 A 313 TYR LEU ASN LYS LEU GLN GLN HIS SER ASP LYS ILE ILE SEQRES 8 A 313 ARG LEU TYR ASP TYR GLU ILE THR ASP GLN TYR ILE TYR SEQRES 9 A 313 MET VAL MET GLU CYS GLY ASN ILE ASP LEU ASN SER TRP SEQRES 10 A 313 LEU LYS LYS LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SEQRES 11 A 313 SER TYR TRP LYS ASN MET LEU GLU ALA VAL HIS THR ILE SEQRES 12 A 313 HIS GLN HIS GLY ILE VAL HIS SER ASP LEU LYS PRO ALA SEQRES 13 A 313 ASN PHE LEU ILE VAL ASP GLY MET LEU LYS LEU ILE ASP SEQRES 14 A 313 PHE GLY ILE ALA ASN GLN MET GLN PRO ASP THR THR SER SEQRES 15 A 313 VAL VAL LYS ASP SER GLN VAL GLY TPO VAL ASN TYR MET SEQRES 16 A 313 PRO PRO GLU ALA ILE LYS ASP MET SER SER SER ARG GLU SEQRES 17 A 313 ASN GLY LYS SER LYS SER LYS ILE SER PRO LYS SER ASP SEQRES 18 A 313 VAL TRP SER LEU GLY CYS ILE LEU TYR TYR MET THR TYR SEQRES 19 A 313 GLY LYS THR PRO PHE GLN GLN ILE ILE ASN GLN ILE SER SEQRES 20 A 313 LYS LEU HIS ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU SEQRES 21 A 313 PHE PRO ASP ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU SEQRES 22 A 313 LYS CYS CYS LEU LYS ARG ASP PRO LYS GLN ARG ILE SER SEQRES 23 A 313 ILE PRO GLU LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN SEQRES 24 A 313 THR HIS PRO VAL ASN GLN MET ALA LYS GLY THR THR GLU SEQRES 25 A 313 GLU MODRES 4C4F TPO A 686 THR PHOSPHOTHREONINE HET TPO A 686 11 HET 7PE A1796 10 HET 7PE A1797 7 HET 7PE A1798 13 HET 7CE A1799 23 HET EDO A1800 4 HET EDO A1801 4 HET EDO A1802 4 HETNAM TPO PHOSPHOTHREONINE HETNAM 7PE 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY) HETNAM 2 7PE ETHOXY)ETHANOL HETNAM 7CE N-(2-METHOXYPHENYL)-2-(1,3-OXAZOL-5-YL)-1H-PYRROLO[3,2- HETNAM 2 7CE C]PYRIDIN-6-AMINE HETNAM EDO 1,2-ETHANEDIOL HETSYN TPO PHOSPHONOTHREONINE HETSYN 7PE POLYETHYLENE GLYCOL FRAGMENT HETSYN EDO ETHYLENE GLYCOL FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 7PE 3(C14 H30 O7) FORMUL 5 7CE C17 H14 N4 O2 FORMUL 6 EDO 3(C2 H6 O2) FORMUL 9 HOH *28(H2 O) HELIX 1 1 ASP A 561 SER A 582 1 22 HELIX 2 2 LEU A 609 LYS A 616 1 8 HELIX 3 3 ASP A 620 GLN A 640 1 21 HELIX 4 4 LYS A 649 ALA A 651 5 3 HELIX 5 5 PRO A 691 ASP A 697 1 7 HELIX 6 6 SER A 712 GLY A 730 1 19 HELIX 7 7 ASN A 739 ASP A 749 1 11 HELIX 8 8 GLU A 761 LEU A 772 1 12 HELIX 9 9 SER A 781 ALA A 787 1 7 HELIX 10 10 HIS A 788 ILE A 793 1 6 SHEET 1 AA 6 SER A 517 VAL A 520 0 SHEET 2 AA 6 ARG A 523 SER A 533 -1 O ARG A 523 N VAL A 520 SHEET 3 AA 6 SER A 537 LEU A 543 -1 O VAL A 539 N ILE A 531 SHEET 4 AA 6 ILE A 549 ASN A 556 -1 O TYR A 550 N VAL A 542 SHEET 5 AA 6 TYR A 597 MET A 602 -1 O ILE A 598 N VAL A 555 SHEET 6 AA 6 LEU A 588 ILE A 593 -1 N TYR A 589 O VAL A 601 SHEET 1 AB 3 ILE A 607 ASP A 608 0 SHEET 2 AB 3 PHE A 653 ILE A 655 -1 N ILE A 655 O ILE A 607 SHEET 3 AB 3 LEU A 660 LEU A 662 -1 O LYS A 661 N LEU A 654 LINK C GLY A 685 N TPO A 686 1555 1555 1.37 LINK C TPO A 686 N VAL A 687 1555 1555 1.33 SITE 1 AC1 5 LYS A 553 VAL A 555 TYR A 568 GLU A 571 SITE 2 AC1 5 MET A 600 SITE 1 AC2 4 TRP A 622 LYS A 625 SER A 626 LYS A 629 SITE 1 AC3 6 ASN A 576 GLN A 580 LEU A 588 TYR A 589 SITE 2 AC3 6 TYR A 591 ASP A 766 SITE 1 AC4 13 ILE A 531 GLN A 541 ALA A 551 LYS A 553 SITE 2 AC4 13 ILE A 586 MET A 602 GLU A 603 CYS A 604 SITE 3 AC4 13 GLY A 605 ASP A 608 LEU A 654 ILE A 663 SITE 4 AC4 13 HOH A2028 SITE 1 AC5 4 PRO A 750 LYS A 773 ARG A 774 ASP A 775 SITE 1 AC6 4 ASP A 595 HIS A 636 HIS A 639 ILE A 782 SITE 1 AC7 4 VAL A 644 SER A 646 GLY A 666 HOH A2015 CRYST1 70.580 111.330 112.120 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014168 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008982 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008919 0.00000